Clinical Trial

Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing

Study acronym: CYP-FAST
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to explore whether genetic testing can offer a personalized and timely approach to assist physicians in making more informed medication decisions for stroke or high-risk transient ischemic attack (TIA) patients during their hospital stay.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-17.
Trial Details
NCT Number NCT06943586
Lead Sponsor University of Alabama at Birmingham
Conditions Stroke, Transient Ischemic Attack (TIA)
Enrollment 200 participants
Start Date 2025-04-09
Primary Completion 2028-04-01 (estimated)
Study Completion 2029-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-23